Global Parkinson's Disease Market and Competitive Landscape - 2017 - Product Image

Global Parkinson's Disease Market and Competitive Landscape - 2017

  • ID: 4377685
  • Report
  • Region: Global
  • Fore Pharma
1 of 3
The latest research, Global Parkinson's Disease Market and Competitive Landscape - 2017, provides comprehensive insights into Parkinson's Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Parkinson's Disease market size and drug sales. This research also provides insights into Parkinson's Disease epidemiology and late stage pipeline.

The report is classified into twelve sections - Parkinson's Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Parkinson's Disease pipeline insights covering late stage clinical trials pipeline; Parkinson's Disease prevalence trends by countries; Parkinson's Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:
  • Parkinson's Disease pipeline: Find out the drugs in clinical trials for Parkinson's Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Parkinson's Disease epidemiology: Find out the prevalence of Parkinson's Disease by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Parkinson's Disease products: Identify key products marketed and prescribed for Parkinson's Disease by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Parkinson's Disease market size: Find out the market size for Parkinson's Disease drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Parkinson's Disease drug sales: Find out the sales of Parkinson's Disease drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Parkinson's Disease drugs sales forecast: Sales forecast for Parkinson's Disease drugs to 2021 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Parkinson's Disease market share analysis: Find out the market shares of Parkinson's Disease drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Parkinson's Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Parkinson's Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Parkinson's Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Parkinson's Disease: Disease Overview
1.1. Parkinson's Disease Symptoms
1.2. Parkinson's Disease Etiology
1.3. Parkinson's Disease Diagnosis
1.4. Parkinson's Disease Treatment Options

2. Parkinson's Disease Pipeline Insights
2.1. Parkinson's Disease Phase 3 Clinical Trials
2.2. Parkinson's Disease Phase 2 Clinical Trials
2.3. Parkinson's Disease Phase 1 Clinical Trials

3. Parkinson's Disease Epidemiology Analysis

4. US Parkinson's Disease Market Insights
4.1. Marketed Products for Parkinson's Disease in US
4.2. US Parkinson's Disease Market Size & Forecast
4.3. US Parkinson's Disease Product Sales Forecast
4.4. US Parkinson's Disease Market Share Analysis

5. Germany Parkinson's Disease Market Insights
5.1. Marketed Products for Parkinson's Disease in Germany
5.2. Germany Parkinson's Disease Market Size & Forecast
5.3. Germany Parkinson's Disease Product Sales Forecast
5.4. Germany Parkinson's Disease Market Share Analysis

6. France Parkinson's Disease Market Insights
6.1. Marketed Products for Parkinson's Disease in France
6.2. France Parkinson's Disease Market Size & Forecast
6.3. France Parkinson's Disease Product Sales Forecast
6.4. France Parkinson's Disease Market Share Analysis

7. Italy Parkinson's Disease Market Insights
7.1. Marketed Products for Parkinson's Disease in Italy
7.2. Italy Parkinson's Disease Market Size & Forecast
7.3. Italy Parkinson's Disease Product Sales Forecast
7.4. Italy Parkinson's Disease Market Share Analysis

8. Spain Parkinson's Disease Market Insights
8.1. Marketed Products for Parkinson's Disease in Spain
8.2. Spain Parkinson's Disease Market Size & Forecast
8.3. Spain Parkinson's Disease Product Sales Forecast
8.4. Spain Parkinson's Disease Market Share Analysis

9. UK Parkinson's Disease Market Insights
9.1. Marketed Products for Parkinson's Disease in UK
9.2. UK Parkinson's Disease Market Size & Forecast
9.3. UK Parkinson's Disease Product Sales Forecast
9.4. UK Parkinson's Disease Market Share Analysis

10. Europe Parkinson's Disease Market Insights
10.1. Europe Parkinson's Disease Market Size & Forecast
10.2. Europe Parkinson's Disease Product Sales Forecast
10.3. Europe Parkinson's Disease Market Share Analysis

11. Japan Parkinson's Disease Market Insights
11.1. Marketed Products for Parkinson's Disease in Japan
11.2. Japan Parkinson's Disease Market Size & Forecast
11.3. Japan Parkinson's Disease Product Sales Forecast
11.4. Japan Parkinson's Disease Market Share Analysis

12. Global Parkinson's Disease Market Insights
12.1. Global Parkinson's Disease Market Size & Forecast
12.2. Global Parkinson's Disease Product Sales Forecast
12.3. Global Parkinson's Disease Market Share Analysis

13. Research Methodology

List of Tables:
Table 1: Parkinson's Disease Phase 3 Clinical Trials, Global, 2017
Table 2: Parkinson's Disease Phase 2 Clinical Trials, Global, 2017
Table 3: Parkinson's Disease Phase 1 Clinical Trials, Global, 2017
Table 4: Parkinson's Disease Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Parkinson's Disease in US, 2017
Table 6: US Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 8: US Parkinson's Disease Market Trends, 2012 - 2021
Table 9: Marketed Products for Parkinson's Disease in Germany, 2017
Table 10: Germany Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 12: Germany Parkinson's Disease Market Trends, 2012 - 2021
Table 13: Marketed Products for Parkinson's Disease in France, 2017
Table 14: France Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 16: France Parkinson's Disease Market Trends, 2012 - 2021
Table 17: Marketed Products for Parkinson's Disease in Italy, 2017
Table 18: Italy Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 20: Italy Parkinson's Disease Market Trends, 2012 - 2021
Table 21: Marketed Products for Parkinson's Disease in Spain, 2017
Table 22: Spain Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 24: Spain Parkinson's Disease Market Trends, 2012 - 2021
Table 25: Marketed Products for Parkinson's Disease in UK, 2017
Table 26: UK Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 28: UK Parkinson's Disease Market Trends, 2012 - 2021
Table 29: Europe Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Parkinson's Disease in Japan, 2017
Table 32: Japan Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 34: Japan Parkinson's Disease Market Trends, 2012 - 2021
Table 35: Global Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Parkinson's Disease Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Parkinson's Disease Pipeline by Phase (%), Global, 2017
Figure 2: Parkinson's Disease Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 4: US Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 5: US Parkinson's Disease Market Share by Products (%), 2016
Figure 6: US Parkinson's Disease Market - Future Market Share (%), 2021
Figure 7: Germany Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 8: Germany Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 9: Germany Parkinson's Disease Market Share by Products (%), 2016
Figure 10: Germany Parkinson's Disease Market - Future Market Share (%), 2021
Figure 11: France Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 12: France Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 13: France Parkinson's Disease Market Share by Products (%), 2016
Figure 14: France Parkinson's Disease Market - Future Market Share (%), 2021
Figure 15: Italy Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 16: Italy Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 17: Italy Parkinson's Disease Market Share by Products (%), 2016
Figure 18: Italy Parkinson's Disease Market - Future Market Share (%), 2021
Figure 19: Spain Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 20: Spain Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 21: Spain Parkinson's Disease Market Share by Products (%), 2016
Figure 22: Spain Parkinson's Disease Market - Future Market Share (%), 2021
Figure 23: UK Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 24: UK Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 25: UK Parkinson's Disease Market Share by Products (%), 2016
Figure 26: UK Parkinson's Disease Market - Future Market Share (%), 2021
Figure 27: Europe Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 28: Europe Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 29: Europe Parkinson's Disease Market Share by Products (%), 2016
Figure 30: Europe Parkinson's Disease Market - Future Market Share (%), 2021
Figure 31: Japan Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 32: Japan Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 33: Japan Parkinson's Disease Market Share by Products (%), 2016
Figure 34: Japan Parkinson's Disease Market - Future Market Share (%), 2021
Figure 35: Global Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 36: Global Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 37: Global Parkinson's Disease Market Share by Products (%), 2016
Figure 38: Global Parkinson's Disease Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll